The Spanish Society of Medicinal Chemistry: Promoting Pharmaceutical R&D in Spain since 1977.

IF 3.6 4区医学 Q2 CHEMISTRY, MEDICINAL ChemMedChem Pub Date : 2024-10-10 DOI:10.1002/cmdc.202400511

José-Manuel Bartolomé-Nebreda, Beatriz de Pascual-Teresa, Marta Gutiérrez-Rodríguez, Mercedes Martín-Martínez

{"title":"The Spanish Society of Medicinal Chemistry: Promoting Pharmaceutical R&D in Spain since 1977.","authors":"José-Manuel Bartolomé-Nebreda, Beatriz de Pascual-Teresa, Marta Gutiérrez-Rodríguez, Mercedes Martín-Martínez","doi":"10.1002/cmdc.202400511","DOIUrl":null,"url":null,"abstract":"<p><p>The Spanish Society of Medicinal Chemistry (Sociedad Española de Química Terapéutica SEQT), founded in 1977, aims to advance pharmaceutical research and education in Spain, collaborating with academia, industry, and public entities. It was initially linked with the Institute of Medicinal Chemistry from Spanish National Research Council (IQM-CSIC), emphasizing the independence of medicinal chemistry as a discipline. SEQT's presidency rotates between representatives from universities, research institutes, and industry, ensuring diverse perspectives. With around 500 members, SEQT represents sectors including universities, CSIC, and industry, with a notable presence of early-career researchers. The Society actively participates in the European Federation for Medicinal chemistry and Chemical biology (EFMC). SEQT organizes conferences, summer schools, and mini symposia to facilitate networking and knowledge exchange among professionals. To support early-career scientists, SEQT organizes symposia and awards, recognizing achievements in drug discovery. It fosters mentorship opportunities and engages with international networks like EFMC-YSN. In 2023, SEQT established its Early Career Scientist (SEQT-ECS) group to provide tailored support and resources. With over 40 years of experience, SEQT continues to evolve, embracing social media and adapting to changes in medicinal chemistry and chemical biology. It remains committed to supporting its members and advancing research to address human health challenges.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemMedChem","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/cmdc.202400511","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

Abstract

The Spanish Society of Medicinal Chemistry (Sociedad Española de Química Terapéutica SEQT), founded in 1977, aims to advance pharmaceutical research and education in Spain, collaborating with academia, industry, and public entities. It was initially linked with the Institute of Medicinal Chemistry from Spanish National Research Council (IQM-CSIC), emphasizing the independence of medicinal chemistry as a discipline. SEQT's presidency rotates between representatives from universities, research institutes, and industry, ensuring diverse perspectives. With around 500 members, SEQT represents sectors including universities, CSIC, and industry, with a notable presence of early-career researchers. The Society actively participates in the European Federation for Medicinal chemistry and Chemical biology (EFMC). SEQT organizes conferences, summer schools, and mini symposia to facilitate networking and knowledge exchange among professionals. To support early-career scientists, SEQT organizes symposia and awards, recognizing achievements in drug discovery. It fosters mentorship opportunities and engages with international networks like EFMC-YSN. In 2023, SEQT established its Early Career Scientist (SEQT-ECS) group to provide tailored support and resources. With over 40 years of experience, SEQT continues to evolve, embracing social media and adapting to changes in medicinal chemistry and chemical biology. It remains committed to supporting its members and advancing research to address human health challenges.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

西班牙药物化学学会（Sociedad Española de Química Terapéutica，SEQT）成立于 1977 年，旨在与学术界、工业界和公共实体合作，推动西班牙的药物研究和教育。它最初与西班牙国家研究理事会药物化学研究所（IQM-CSIC）建立了联系，强调药物化学作为一门学科的独立性。SEQT 的主席由来自大学、研究机构和企业的代表轮流担任，以确保观点的多样性。SEQT 拥有约 500 名会员，代表了包括大学、CSIC 和企业在内的各个领域，其中不乏早期职业研究人员。学会积极参与欧洲药物化学和化学生物学联合会（EFMC）的活动。SEQT 举办会议、暑期学校和小型研讨会，以促进专业人员之间的联系和知识交流。为了支持早期职业科学家，SEQT 还组织研讨会和颁奖活动，表彰在药物发现方面取得的成就。它还提供导师机会，并与 EFMC-YSN 等国际网络合作。2023 年，SEQT 成立了早期职业科学家小组 (SEQT-ECS)，以提供量身定制的支持和资源。拥有 40 多年经验的 SEQT 将继续发展，拥抱社交媒体，适应药物化学和化学生物学的变化。它将一如既往地致力于为会员提供支持，推动研究工作，以应对人类健康挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

ChemMedChem 医学-药学

CiteScore

6.70

自引率

2.90%

发文量

280

审稿时长

1 months

期刊介绍： Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.